A human ESC line for efficient CRISPR editing of pluripotent stem cells

Human pluripotent stem cells (hPSC) can be directed to differentiate in vitro into insulin-prorducing beta cells (SC-β). Although these cells accurately respond to glucose and can reverse diabetes in preclinical models improvments in the final cell products are desirable. For example, safety, contro...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elad Sintov, Dario Gerace, Douglas A. Melton
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/c13124af03dd436c9fac4750b2a61845
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!